Evita Sadimin, M.D.
Clinical Informatics, American Board of Pathology
Anatomical and Clinical Pathology, American Board of Pathology
2009, M.D. Robert Wood Johnson Medical School, Piscataway, NJ
2003, B.A., Biological Chemistry, Rutgers University, New Brunswick, NJ
2014-2015, Fellow, Genitourinary Pathology, Johns Hopkins Medical Institutions, Baltimore, MD
2011-2012, Fellow, Pathology Informatics, Rutgers Robert Wood John Medical School, New Brunswick, NJ
2009-2014, Resident in Anatomical and Clinical Pathology, Rutgers Robert Wood John Medical School, New Brunswick, NJ
2012-2013, Chief Resident, Rutgers Robert Wood John Medical School, New Brunswick, NJ
2021-present, Chief, Division of Informatics and Data Science, Department of Pathology, City of Hope, CA
2021-present, Associate Professor, Department of Pathology and Laboratory Medicine, Rutgers Robert Wood Johnson Medical School, Rutgers Cancer Institute of New Jersey, NJ
2020-present, Core faculty, Rutgers Global Health Institute
2018-present, Director of Genitourinary Pathology, Department of Pathology and Laboratory Medicine, Rutgers Robert Wood Johnson Medical School
2016-present, Director of Pathology Informatics, Department of Pathology and Laboratory Medicine, Rutgers Robert Wood Johnson Medical School
2015-2021, Assistant Professor, Department of Pathology and Laboratory Medicine, Rutgers Robert Wood Johnson Medical School, Rutgers Cancer Institute of New Jersey, NJ
2019, Jerome H. Strauss Award, Binford-Dammin Society of Infectious Disease Pathology
2018, Certificate of Recognition in Data Integration, Rutgers Health
2018, Immuno-Oncology Leadership Cohort Recognition, American Society for Clinical Pathology
2011, Association of Pathology Informatics Travel Award, Association of Pathology Informatics
2003, Bruce Garth Award for Excellence in Chemistry, Rutgers University
2002, Organic Chemistry Excellence Award, Croda International
2002-2003, George H. Cook Honors Scholar, Rutgers University
2000-2003, William H. Martin Scholarship Award, Rutgers University
2000-2003, Class of 1925 Scholarship Award, Rutgers University
College of American Pathologists, Committee Member
United States & Canadian Academy of Pathology
Association of Pathology Informatics
Genitourinary Pathology Society
International Society of Urological Pathology
- Foran D, Durbin E, Chen W, Sadimin E, Sharma A, Banerjee I, Kurc T, Li N, Stroup A, Harris G, Gu A, Schymura M, Gupta R, Bremer E, Balsamo J, DiPrima T, Wang F, Abousamra S, Samaras D, Hands I, Ward K, Saltz J. An expandable informatics framework for enhancing central cancer registries with digital pathology specimens, computational imaging tools, and advanced mining capabilities. Journal of Pathology Informatics 2022:13:5.
- Sterling J, Smith K, Farber N, Nagaya N, Jang T, Singer E, Sadimin E, Kim I. Fourteen-core systematic biopsy that includes two anterior cores in men with PI-RADS lesion equal or greater than 3 is comparable with magnetic resonance imaging-ultrasound fusion biopsy in detecting clinically significant prostate cancer: a single-institution experience. Clinical Genitourinary Cancer 2021:19(4):275-279.
- Srivastava A, Rivera-Núñez Z, Kim S, Sterling J, Farber N, Radadia K, Patel H, Modi P, Goyal S, Parikh R, Mayer T, Saraiya B, Sadimin E, Weiss R, Kim I, Elsamra S, Jang T, Singer E. Impact of Pathologic Node Positive Renal Cell Carcinoma on Survival in Patients without Metastasis: Evidence in Support of Expanding the Definition of Stage IV Kidney Cancer. Cancer 2020:126(13):2991-3001.
- Ren J, Singer E, Sadimin E, Foran D, Qi X. Statistical analysis of survival models using feature quantification on prostate cancer histopathology images. Journal of Pathology Informatics 2019:10:30.
- Wang L, Zhang Y, Chen Y, Skala S, Al-Ahmadie H, Wang X, Cao X, Veeneman B, Chen J, Cieślik M, Qiao Y, Su F, Vats P, Siddiqui J, Xiao H, Sadimin E, Epstein J, Zhou M, Sangoi A, Trpkov K, Osunkoya A, Giannico G, McKenney J, Argani P, Tickoo S, Reuter V, Chinnaiyan A, Dhanasekaran S, Mehra R. VSTM2A overexpression is a sensitive and specific biomarker for mucinous tubular and spindle cell carcinoma (MTSCC) of the kidney. American Journal of Surgical Pathology 2018:42(12):1571-1584.
- Sadimin E, Chen Y, Wang L, Argani P, Epstein J. Chromosomal abnormalities of high-grade mucinous tubular and spindle cell carcinoma of the kidney. Histopathology 2017:71(5):719-724.
- Foran D, Chen W, Chu H, Sadimin E, Loh D, Riedlinger G, Goodell L, Ganesan S, Hirshfield K, Rodriguez L, DiPaola R. Roadmap to a comprehensive clinical data warehouse for precision medicine applications in oncology. Cancer Informatics 2017:16:1-10.
- Sadimin E, Khani F, Diolombi M, Meliti A, Epstein J. Interobserver reproducibility of percent pattern 4 in prostatic adenocarcinoma on prostate biopsies. American Journal of Surgical Pathology 2016:40:1686-1692.
- Sadimin E, Epstein J. Round cell pattern of prostatic stromal tumor of uncertain malignant potential: A subtle newly recognized variant. Human Pathology 2016:52:68-73.
- Sadimin E, Ye H, Epstein J. Should the involvement of skeletal muscle at the prostate apex by prostatic adenocarcinoma be reported on biopsies? Human Pathology 2016:49:10-14.
- Kim I, Modi P, Sadimin E, Ha Y, Kim J, Skarecky D, Cha D, Wambi C, Ou Y, Yuh B, Park S, Llukani E, Albala D, Wilson T, Ahlering T, Badani K, Ahn H, Lee D, May M, Kim W, Lee D. Detailed analysis of patients with metastasis to the prostatic anterior fat pad lymph nodes: A multi-institutional study. The Journal of Urology 2013:190(2):527-534.
- Sadimin E, Foran D. Pathology imaging informatics for clinical practice and investigative and translational research. North American Journal of Medicine and Science 2012;5(2):103-109.